
Biomarker Testing in Advanced NSCLC: A Pathology Perspective
Chung-Che (Jeff) Chang, MD, PhD
Medical Director,
Hematology and Molecular Pathology Labs,
Florida Hospital Cancer Institute,
Orlando, Florida
Dr. Chang discusses how to improve biomarker testing success rates in NSCLC through optimizing sample selection and instituting protocols that reduce front-end turnaround time
CASE STUDY ON BIOMARKER TESTING IN ADVANCED NSCLC

Case Study
Patient Case: Biomarker Testing in Advanced NSCLC

Chung-Che (Jeff) Chang, MD, PhD
A Case-Based Pathology Perspective on Biomarker Testing in NSCLC

Gaetane C. Michaud, MD
A Case-Based Pulmonology Perspective on Biomarker Testing in NSCLC

Mark A. Socinski, MD
A Case-Based Oncology Perspective on Biomarker Testing in NSCLC
IN ADVANCED NSCLC

Chung-Chee (Jeff) Chang, MD, PhD
A Pathology Perspective on Biomarker Testing in NSCLC

Martin Dietrich, MD, PhD
A Community Oncology Perspective on Biomarker Testing in NSCLC

Gaetane C. Michaud, MD
A Pulmonology Perspective on Biomarker Testing in NSCLC

Mark A. Socinski, MD
An Oncology Perspective on Biomarker Testing in NSCLC